ICI treatment was significantly associated with improved MSS in “melanocytic-low” patients and showed a trend toward benefit in the melanocytic-high group ( Fig. 5B ).
← all excerpts
The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma.
1
—
—